Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table5: Comparison of 5-year absolute and relative survival of cases diagnosed between 1981-1990 and 1991-1999

(Tianjin, China)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	5-year absolute survival %		5-year relative survival %
Site	ICD-10	82-91	92-2000	82-91	92-2000
C00	Lip	84.8	80.3	103.3	97.6
C01-02	Tongue	46.7	59.2	53.9	67.8
C03-06	Oral cavity	61.1	55.6	68.9	64.6
C07-08	Salivary gland	67.5	78.7	72.3	88.9
C09	Tonsil	37.5	72.7	40.4	87.2
C11	Nasopharynx	50.8	50.5	55.1	55.3
C12-13	Hypopharynx	49.3	65.4	56.4	78.6
C15	Oesophagus	23.1	26.9	27.9	33.4
C16	Stomach	28.5	34.4	33.4	41.3
C17	Small intestine	50.0	50.4	55.2	57.4
C18	Colon	43.8	52.5	49.4	61.4
C19-20	Rectum	40.4	48.1	45.8	56.0
C21	Anus	42.9	66.2	49.2	81.9
C22	Liver	15.1	21.3	17.4	25.1
C23-24	Gall bladder	31.7	39.1	36.6	47.3
C25	Pancreas	20.3	25.2	23.4	29.8
C30-31	Nose/Sinuses	47.6	58.5	52.2	66.6
C32	Larynx	53.1	54.0	60.9	64.6
C33-34	Lung	24.5	25.7	28.2	30.9
C37-38	Other thoracic organs	42.9	46.2	46.7	51.8
C40-41	Bone	24.8	25.0	27.6	27.8
C43	Melanoma skin	54.1	56.0	62.5	63.9
C44	Other skin	57.6	72.8	69.1	89.0
C45	Mesothelioma	29.6	49.8	32.9	58.5
C47+C49	Connective tissue	67.6	71.9	73.8	79.8
C50	Breast	75.4	79.8	80.1	84.8
C51	Vulva	67.7	61.2	77.6	71.3
C53	Cervix	55.3	53.8	62.0	62.4
C54	Corpus uteri	77.5	85.5	82.8	91.3
C55	Uterus unspecified	36.6	18.9	41.8	22.0
C56	Ovary	52.4	59.7	55.7	63.6
C57	Other female genital	56.8	60.9	60.2	64.3
C58	Placenta	85.0	93.3	86.0	94.1
C60	Penis	61.1	75.1	76.7	96.6
C61	Prostate	41.0	52.5	56.0	72.0
C62	Testis	73.1	66.8	75.9	68.6
C64	Kidney	48.6	52.6	55.5	60.6
C65	Renal pelvis	80.0	78.8	90.5	95.7
C66	Ureter	54.5	63.1	59.3	74.4
C67	Urinary bladder	53.8	59.6	63.9	74.6
C69	Eye	65.1	79.1	71.0	87.4
C70-72	Brain & nervous system	38.8	39.9	40.9	43.3
C73	Thyroid	78.2	79.4	82.1	85.4
C74	Adrenal gland	60.0	69.7	64.5	73.5
C75	Other endocrine	89.2	96.7	92.1	100.8
C81	Hodgkin lymphoma	59.8	77.8	61.4	81.1
C82-85+C96	Non-Hodgkin lymphoma	44.5	42.8	49.2	48.0
C90	Multiple myeloma	19.2	40.6	22.2	45.7
C91	Lymphoid leukaemia	58.2	61.6	61.6	66.0
C92-94	Myeloid leukaemia	44.5	63.1	46.9	67.6
C95	Leukaemia unspecified	13.1	19.4	14.4	21.8

Graphs:

5-year absolute survival comparison

5-year relative survival comparison

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table5:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1981-1990 and 1991-1999 (Tianjin, China)
- Table6:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Tianjin, China, 1991-1999 cases followed-up until 2000)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)